X-Nav Technologies Recaps AAOMS 2022

 

 

The 104th annual meeting of the American Association of Oral and Maxillofacial Surgeons (AAOMS) took place in New Orleans on September 12-15, 2022, and brought together oral surgeons from around the globe. The AAOMS 2022 conference centered around the theme “Volunteerism: Individuals United in Service,” with many courses and educational sessions allowing attendees to earn up to 32 C.E. credits, doubling the typical number from past years​​. The exhibit hall teemed with over 200 exhibitors, showcasing cutting-edge oral and maxillofacial surgery products, services, and technologies. One of these exhibitors was X-Nav Technologies, marking its tenth anniversary at the event​​.

What makes this milestone for X-Nav Technologies particularly significant? How have they transformed the landscape of oral and maxillofacial surgery over the past decade, and what can we expect from them in the years to come?

In this episode of On-Point by X-Nav Technologies, co-founder and VP of Sales Chris Scharff recapped the AAOMS 2022 meeting and discussed the strides X-Nav has made over the last decade. Highlights from the conference include:

  • X-Nav’s celebration of their tenth anniversary and their presence at the AAOMS meeting, where they engaged with existing customers and met with potential new ones
  • Their X-Guide navigation system, now installed in over 45 countries and has facilitated over 2,000 implants, demonstrating its global impact and staying power in the industry
  • The exceptional accuracy of the X-Guide system

Apart from being the co-founder and V.P. of Sales at X-Nav Technologies, Chris Scharff has an extensive dental technology background. His leadership and sales acumen have driven the company’s growth and innovation over the past ten years. As a stalwart advocate for emerging technologies in the field, Chris continues to push the boundaries of what’s possible in oral and maxillofacial surgery, ensuring X-Nav remains at the forefront of industry advancements.

 

Recent Episodes

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…